Currently holds positions in Quest Diagnostics Inc and Myovant Sciences Ltd
Position | Company | Period |
---|---|---|
Chief Financial Officer, Executive Vice President | Quest Diagnostics Inc | July 29, 2013 - |
Director | Myovant Sciences Ltd | July 23, 2018 - |
Chief Financial Officer, Senior Vice President | Hill-Rom Holdings Inc | Dec. 13, 2010 - July 26, 2013 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2020-12-28 | 2020-12-24 |
Quest Diagnostics Inc
(DGX)
|
PS Planned sale |
22,563
-23.5%
121.182,734,139 USD |
22,563 -23.5% | 121.18 | 2,734,139 USD | |
2020-12-28 | 2020-12-24 |
Quest Diagnostics Inc
(DGX)
|
PS Planned sale |
59,193
-38.1%
120.067,106,534 USD |
59,193 -38.1% | 120.06 | 7,106,534 USD | |
2020-06-10 | 2020-06-08 |
Quest Diagnostics Inc
(DGX)
|
PS Planned sale |
8,524
-10.4%
118.601,010,980 USD |
8,524 -10.4% | 118.60 | 1,010,980 USD | |
2020-06-10 | 2020-06-08 |
Quest Diagnostics Inc
(DGX)
|
PS Planned sale |
18,246
-18.2%
117.652,146,624 USD |
18,246 -18.2% | 117.65 | 2,146,624 USD | |
2020-06-10 | 2020-06-08 |
Quest Diagnostics Inc
(DGX)
|
PS Planned sale |
45,826
-31.4%
116.815,352,981 USD |
45,826 -31.4% | 116.81 | 5,352,981 USD | |
2019-06-17 | 2019-06-13 |
Quest Diagnostics Inc
(DGX)
|
S Sale |
73,005
-52.5%
100.007,300,500 USD |
73,005 -52.5% | 100.00 | 7,300,500 USD |